IRON DEFICIENCY ANEMIA
F.A. Rice, ART, CLS
March 1, 1996
Please send comments to: F.A. Rice
This lecture will concentrate on iron deficiency anemia. For
discussion on anemia in general refer to the University of Washington or
the Healthnet.
Iron deficiency anemia is the most common anemia in the world.
Iron is an essential component of the hemoglobin molecule, without
iron the marrow is unable to produce hemoglobin. The red cell
number falls and those which do reach the circulation are smaller
than normal (microcytic) and lack hemoglobin, hence they are pale
and under colored (hypochromic). The deficiency in iron may be
absolute, that is, there is no iron available for the production of
hemoglobin, this is true iron deficiency anemia. The deficiency
may be relative, that is, the iron is present in storage in the
marrow but is unavailable for hemoglobin production, this is anemia
of chronic disease.
Outline:
The amount of iron present varies with the body size, age and sex
of the individual.
- -2 gm - 5 gm in average adult
- -4 gm average in the adult male
- -2.5 gm average in the adult female
The average normal North American diet contains approximately
15-20 mg of iron. Most is present in meat and green vegetables.
Approximately 1.0 mg is absorbed each day and just about an equal
amount is lost in the feces and sweat. As a result, the average
adult is in a tenuous state of balance. This delicate balance is
of little consequence as there is slightly more iron absorbed than
lost and a store of iron is accumulated. If, however, the rate of
iron loss increases, usually through blood loss such as chronic
bleeding, these stores can be depleted and an absolute iron deficiency
develops.
The majority of the iron present is present as hemoglobin iron.
Approximately 25% of the iron is maintained as storage iron
(ferritin and hemosiderin) primarily in the bone marrow.
- hemoglobin 65 to 70% 1.5 to 3.0 gm
- storage
ferritin
hemosiderin 20 to 30% 0.5 to 1.5 gm
- other
myoglobin
heme enzyme remainder
Iron absorption occurs primarily in the duodenum. Most of this
iron is in the ferric (+++) form and is complexed to other organic
and inorganic molecules. The acid in the stomach and hydrolytic
enzymes in the small intestine release the iron from these
complexes. It is then reduced to the ferrous (++) form as it is
more readily absorbed in this state. Absorption is increased by
the presence of:
glucose
fructose
some amino acids
ascorbic acid (Vitamin C)
These substances aid in the absorption process by either reducing
ferric iron to the ferrous state or by helping bind the iron to the
mucosal cell receptor sites. It is recognition of the positive
effects of vitamin C which has resulted in many iron supplements
being manufactured with this vitamin present. Heme iron, iron in
meat myoglobin, is more easily absorbed than elemental iron. Iron
absorption is decreased by the presence of:
phosphate
bicarbonate
bile acids
Once the ferrous iron (++) binds to receptors on the surface of
mucosal cells it is moved into the cell. This is an energy dependent
process. In the mucosal cell the iron is oxidized back to the
ferric (+++) state and bound to apoferritin in the cell. This
continues until all the apoferritin bound at which point newly
absorbed iron is no longer oxidized but rather is passed through
the cell and into the portal circulation still in the ferrous
state. In the blood, iron is bound to transferrin in the ferric
state. Bound to transferrin, the iron is transported to the marrow
for use or storage.
The intestinal wall is covered with villi, finger-like projections,
which are covered with absorptive mucosal cells. These cells are
produced in the crypts of Lieberkhun, at the base of the villi, and
move upwards to the villus tip to be disquamated (lost). Each cell
is produced with a set amount of apoferritin. The more iron
required by the body the less apoferritin manufactured in each
cell. In other words, it is the amount of apoferritin within each
mucosal cell which acts as the gatekeeper and regulates the amount
of iron absorbed.
Transferrin is the primary iron transport protein. It is a beta
globulin and is produced in liver. It has a 1/2 life of 8-11 days.
Each molecule of transferrin can bind and transport two molecules
of iron in the ferric (+++) state. Transferrin prefers to carry
iron to the marrow but will carry iron to other organs if the
marrow is damaged or excess amounts of iron are already stored in
the marrow. In rare instances when transferrin is absent
(atransferrinemia) other proteins can bind iron but carry the iron
to other organs such as liver, spleen and pancreas, little if any
is carried to the marrow. As well as specific receptors for iron,
transferrin has specific receptors for sites on the developing
normoblast and RE cell. Once bound to the cell membrane, the
transferrin changes shape and releases the iron. It then returns
to the portal circulation to bind more iron. Under normal circumstances
approximately 1/3 of the transferrin has iron bound to it.
Iron can be transfered to developing red cells either bound to
transferrin or presented as ferritin to the developing cells as
they cluster around "nurse cell" RE cells. The iron is moved into
the developing red cell by a process similar to pinocytosis called
ropheocytosis. Clusters of normoblasts around a nurse cell are
called a "feed islands".
Iron is stored as either ferritin or hemosiderin.
-ferritin consists of an outer protein shell with iron complexed
within the core. The outer shell consists of 22 apoferritin
molecules while the core consists of an iron/phosphate complex
consisting of 4,000 to 5,000 molecules of iron in each core.
Ferritin is water soluble and a very small amount is dissolved in
the plasma. The more ferritin stored the more dissolved in the
plasma. The ferritin reference range for males is 40 to 300 ug/l
and 20 to 150 ug/l for females. Ferritin is not visible by light
microscopy, nor is it stained by the Prussian Blue reaction. It is
preferentially used before hemosiderin, probably because it is
soluble.
-hemosiderin is aggregated ferritin molecules. The protein shell
has been altered and as a result it is water insoluble. It can be
seen by light microscopy as gold-brown granules and is demonstrated
by the Prussian Blue stain.
The adult male requires approximately 1.0 mg/day. Just enough to
cover normal iron loss. The adult female requires approximately
2.0 mg/day. Enough for daily loss and menstruation. Pregnant
females require approximately 3.0 mg. Enough for normal, on going
loss and fetal requirements. Children require approximately
2.0 mg/day. Enough for normal loss and extra to produce some
residual iron stores and allow for increasing red cell mass.
- diet - uncommon except in children
- failure to absorb
- increased utilization
- pregnancy
- adolescent growth
- atransferrinemia
- failure to utilize
- lead poisoning
- chronic diseases
- blood loss
chronic blood loss is the most common cause of iron deficiency anemia.
It must be remembered that anemia in iron deficiency develops
slowly. The type and severity of the anemia varies with time.
Development Stages:
- 1. depletion of iron stores, decreased ferritin levels, no
anemia
- 2. increased transferrin levels, no anemia
- 3. fall in serum iron, no anemia
- 4. development of normocytic, normochromic anemia
- 5. development of microcytic, hypochromic anemia
Routine procedures
Hgb, Hct and RBC count are all decreased. The degree of decrease
depends upon the length of time the marrow has been without
sufficient supplies of iron. It must be remembered that at any
stage the red cell number will not be proportionately as low as is
the Hgb and Hct. This is due to the fact that the marrow can
continue to produce empty cells.
Indices - MCV - decreased, MCH - decreased, MCHC - decreased.
The MCHC is the last to become lowered. This is due to the fact that
as the marrow becomes more and more depleted of iron it produces
smaller cells with a smaller amount of hemoglobin in each in an
attempt to keep the concentration of hemoglobin in each normal. The
RDW is increased which reflects the anisocytosis characteristic of
iron deficiency.
Morphology - changes from normal to simple microcytic to
hypochromic microcytic as the iron deficiency progresses. When full
blown there is marked anisocytosis and poikilocytosis with
elliptocytes and target cells. NRBC may be seen on a rare
occasion.
White cell count and differential - normal
Platelets - normal to increased. They are usually microcytic
and stain very pale and can be missed on film.
Retics - the relative count is decreased to normal while the production index (PI) is decreased.
Special procedures
A bone marrow examination is seldom, if ever, performed or needed
for the diagnosis of an iron deficiency anemia. If however, a bone
marrow is performed the following results would be present.
Bone Marrow
cellularity - normal to increased
morphology - normoblastic with some dyserythropoiesis. Ragged
reduced cytoplasm, vacuoles, multinuclearity, karryohexis, nuclear
budding, abnormal mitosis. All these may be seen but are not the
predominant features of the marrow.
iron stain - absent. The absence of iron is considered to be the
"gold standard" for the diagnosis of iron deficiency.
siderocytes - absent
Serum iron - decreased
TIBC - increased
%saturation - decreased
Ferritin - decreased
Free erythrocyte protoporphyrin (FEP) - increased
NOTE! The above review provides strong
evidence for using serum ferritin as an initial laboratory test for
the evaluation of iron deficiency anemia.
Bilirubin - normal to decreased
Treatment
Iron supplement. The response is monitored with the retic count,
hemoglobin and hematocrit. A failure to respond may be due to:
- 1. continued bleeding
- 2. failure to take iron
- 3. wrong diagnosis
- 4. mixed deficiency
- 5. other causes - inflammation
- 6. malabsorption - unlikely
- 7. use of slow release iron